Compare Exelixis Inc. Common Stock (EXEL) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? Exelixis Inc. Common Stock trades at $60.25 (market cap $14.62B), while UBS Group AG Registered Ordinary Shares trades at $48.18 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 9.8× Exelixis Inc. Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.34% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and UBS Group AG Registered Ordinary Shares for 1 Days on average.
| EXEL | UBS | |
|---|---|---|
Market Cap | $14.62B | $142.70B |
Volume | 2,684,957 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $59.13 | $55.72 |
52-Week Low | $34.54 | $36.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $314.41B |
Dividend Yield | — | 2.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
